These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 20967345)
1. Investigation of the influence of high-risk human papillomavirus on the biochemical composition of cervical cancer cells using vibrational spectroscopy. Ostrowska KM; Malkin A; Meade A; O'Leary J; Martin C; Spillane C; Byrne HJ; Lyng FM Analyst; 2010 Dec; 135(12):3087-93. PubMed ID: 20967345 [TBL] [Abstract][Full Text] [Related]
2. Correlation of p16(INK4A) expression and HPV copy number with cellular FTIR spectroscopic signatures of cervical cancer cells. Ostrowska KM; Garcia A; Meade AD; Malkin A; Okewumi I; O'Leary JJ; Martin C; Byrne HJ; Lyng FM Analyst; 2011 Apr; 136(7):1365-73. PubMed ID: 21290054 [TBL] [Abstract][Full Text] [Related]
3. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid. Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130 [TBL] [Abstract][Full Text] [Related]
4. A spectral phenotype of oncogenic human papillomavirus-infected exfoliative cervical cytology distinguishes women based on age. Kelly JG; Cheung KT; Martin C; O'Leary JJ; Prendiville W; Martin-Hirsch PL; Martin FL Clin Chim Acta; 2010 Aug; 411(15-16):1027-33. PubMed ID: 20359472 [TBL] [Abstract][Full Text] [Related]
5. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer. Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934 [TBL] [Abstract][Full Text] [Related]
6. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo. Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255 [TBL] [Abstract][Full Text] [Related]
7. Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Huang CC; Qiu JT; Kashima ML; Kurman RJ; Wu TC Mod Pathol; 1998 Oct; 11(10):971-7. PubMed ID: 9796725 [TBL] [Abstract][Full Text] [Related]
8. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for cervical neoplasia in Denmark. Kjaer SK APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662 [TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus testing for primary cervical cancer screening. Grce M; Davies P Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808 [TBL] [Abstract][Full Text] [Related]
11. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579 [TBL] [Abstract][Full Text] [Related]
13. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction]. Zheng Y; Peng ZL; Lou JY; Wang H Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998 [TBL] [Abstract][Full Text] [Related]
14. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX; J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827 [TBL] [Abstract][Full Text] [Related]
15. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma. Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542 [TBL] [Abstract][Full Text] [Related]
16. Early detection of cervical neoplasia by Raman spectroscopy. Jess PR; Smith DD; Mazilu M; Dholakia K; Riches AC; Herrington CS Int J Cancer; 2007 Dec; 121(12):2723-8. PubMed ID: 17724716 [TBL] [Abstract][Full Text] [Related]
17. Adenoviral p53 effects and cell-specific E7 protein-protein interactions of human cervical cancer cells. Choi JW; Ahn WS; Bae SM; Lee DB; Kim YW Biosens Bioelectron; 2005 May; 20(11):2236-43. PubMed ID: 15797321 [TBL] [Abstract][Full Text] [Related]
18. Physical status of multiple human papillomavirus genotypes in flow-sorted cervical cancer cells. Vermeulen CF; Jordanova ES; Szuhai K; Kolkman-Uljee S; Vrede MA; Peters AA; Schuuring E; Fleuren GJ Cancer Genet Cytogenet; 2007 Jun; 175(2):132-7. PubMed ID: 17556069 [TBL] [Abstract][Full Text] [Related]
19. Integrating human papillomavirus vaccination in cervical cancer control programmes. Franco EL; Coutlée F; Ferenczy A Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447 [TBL] [Abstract][Full Text] [Related]
20. [Can human papillomavirus testing and vaccination prevent cervical cancer?]. Lie AK; Bjørge T; Helland A; Hagen B; Skjeldestad FE; Hagmar B; Thoresen S Tidsskr Nor Laegeforen; 2001 Oct; 121(25):2947-51. PubMed ID: 11715778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]